DJIA 17,730.91 -67.58 -0.38%
NASDAQ 5,105.73 -21.80 -0.43%
S&P 500 2,083.29 -6.82 -0.33%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Perilous Reversal Stock: ARIAD Pharmaceuticals (ARIA)

Benzinga's Weekend M&A Chatter

Why Ariad Pharmaceuticals Rocketed More Than 40% Higher Today

Baxalta is trying to buy Ariad Pharmaceuticals, but a deal hasn't been finalized.

Barbarian At The Gate: ARIAD Pharmaceuticals (ARIA)

Premarket Biotech Digest: Major Mayo Research, Axovant Still Shortable, Mylan Perrigo Bid

ARIAD Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock

Mid-Day Market Update: Tuesday's Top Shorted Stocks

A Reduced Payout Could Be in the Cards for These High-Yield Dividend Stocks

GlaxoSmithKline and PDL BioPharma offer investors sector-crushing yields at current levels. But there's good reason to believe they won't last much longer.

Health Care Sector Update for 08/10/2015: ARIA, GEN, BDSI

ARIAD Slips on Wider-than-Expected Q2 Loss; Iclusig Grows - Analyst Blog

See More Articles...